BR0014952A - Medicamento contraceptivo e seu modo de preparação - Google Patents

Medicamento contraceptivo e seu modo de preparação

Info

Publication number
BR0014952A
BR0014952A BR0014952-7A BR0014952A BR0014952A BR 0014952 A BR0014952 A BR 0014952A BR 0014952 A BR0014952 A BR 0014952A BR 0014952 A BR0014952 A BR 0014952A
Authority
BR
Brazil
Prior art keywords
contraceptive
preparation
relates
mode
chemistry
Prior art date
Application number
BR0014952-7A
Other languages
English (en)
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0014952(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of BR0014952A publication Critical patent/BR0014952A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

"MEDICAMENTO CONTRACEPTIVO E SEU MODO DE PREPARAçãO". A presente invenção se refere ao campo da química e, mais particularmente, ao da química terapêutica. Tem, mais particularmente, por objeto novas composições contraceptivas compostas por uma progesterona e um estrogênio. Tem, especificamente, por objeto novas composições farmacêuticas contraceptivas caracterizadas pelo fato de incluirem, como agentes ativos, um éster de nomegestrol e estradiol, em associação ou em mistura com um excipiente ou um veículo inerte não tóxico, farmaceuticamente aceitável e conveniente para administração por via oral.
BR0014952-7A 1999-10-25 2000-10-24 Medicamento contraceptivo e seu modo de preparação BR0014952A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (fr) 1999-10-25 1999-10-25 Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
PCT/FR2000/002952 WO2001030358A1 (fr) 1999-10-25 2000-10-24 Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation

Publications (1)

Publication Number Publication Date
BR0014952A true BR0014952A (pt) 2003-07-29

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014952-7A BR0014952A (pt) 1999-10-25 2000-10-24 Medicamento contraceptivo e seu modo de preparação

Country Status (21)

Country Link
EP (2) EP2020236B1 (pt)
JP (1) JP5484646B2 (pt)
KR (1) KR100549625B1 (pt)
CN (1) CN1205936C (pt)
AP (1) AP1707A (pt)
AU (1) AU784478B2 (pt)
BR (1) BR0014952A (pt)
CA (1) CA2388857C (pt)
CR (1) CR6627A (pt)
CZ (1) CZ301982B6 (pt)
ES (1) ES2565688T3 (pt)
HK (2) HK1048600A1 (pt)
HU (1) HU230467B1 (pt)
IL (2) IL149141A0 (pt)
MX (1) MXPA02004083A (pt)
NO (1) NO330885B1 (pt)
NZ (1) NZ518308A (pt)
OA (1) OA12071A (pt)
RU (1) RU2258512C2 (pt)
WO (2) WO2001030355A1 (pt)
ZA (1) ZA200203399B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
KR100975350B1 (ko) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 사람 락토페리신을 생산하는 형질전환 복제 소 및 이것의생산방법
CA2571377C (en) * 2004-07-07 2014-03-25 Wyeth Cyclic progestin regimens and kits
EA015155B1 (ru) * 2005-05-26 2011-06-30 Тева Вуменс Хелс, Инк. Дозированные формы для перорального применения, содержащие прогестерон, и способы их изготовления и использования
CN103877059A (zh) * 2014-03-26 2014-06-25 邵娜 一种醋酸诺美孕酮片及其制备工艺

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
FI101601B (fi) 1987-09-24 1998-07-31 Jencap Res Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmist een valmistusmenetelmässä
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19529767A1 (de) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphile Verbindungen mit mehreren hydrophilen und hydrophoben Gruppen auf der Basis von Aminobernsteinsäurederivaten
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
DE19536742A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischvorrichtung eines Fahrzeuges
DE29515703U1 (de) 1995-10-02 1996-02-08 Foehl Artur Drehantriebsvorrichtung für einen Gurtstraffer
US5820059A (en) 1995-10-02 1998-10-13 Nsk Ltd. Retractor for seat belt
DE19536745A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt für eine Scheibenwischervorrichtung eines Fahrzeuges, insbesondere eines Kraftfahrzeuges
DE19536744A1 (de) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wischblatt mit auswechselbarem Wischgummi für einen Fahrzeugscheibenwischer
EP0770338B1 (en) 1995-10-23 2002-09-25 Honda Access Corp. Cap body of a helmet
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
WO1999009993A1 (en) 1997-08-27 1999-03-04 Ortho Pharmaceutical Corporation Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
CN1270521A (zh) * 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂

Also Published As

Publication number Publication date
HUP0203443A3 (en) 2003-12-29
EP2020236B1 (fr) 2016-01-27
ZA200203399B (en) 2004-02-09
MXPA02004083A (es) 2003-08-20
RU2258512C2 (ru) 2005-08-20
EP2020236A1 (fr) 2009-02-04
NO20021948L (no) 2002-06-25
CR6627A (es) 2008-06-18
CN1382054A (zh) 2002-11-27
PL354518A1 (en) 2004-01-26
AU784478B2 (en) 2006-04-13
JP5484646B2 (ja) 2014-05-07
NZ518308A (en) 2006-01-27
EP1227815A1 (fr) 2002-08-07
HK1048600A1 (zh) 2003-04-11
AP2002002485A0 (en) 2002-06-30
HU230467B1 (hu) 2016-07-28
IL149141A (en) 2008-06-05
CA2388857C (fr) 2011-06-07
HUP0203443A2 (hu) 2003-01-28
ES2565688T3 (es) 2016-04-06
CZ301982B6 (cs) 2010-08-25
AU1033501A (en) 2001-05-08
CN1205936C (zh) 2005-06-15
WO2001030358A1 (fr) 2001-05-03
OA12071A (fr) 2006-05-04
HK1129564A1 (zh) 2009-12-04
IL149141A0 (en) 2002-11-10
WO2001030355A1 (fr) 2001-05-03
KR100549625B1 (ko) 2006-02-08
CA2388857A1 (fr) 2001-05-03
NO20021948D0 (no) 2002-04-25
NO330885B1 (no) 2011-08-08
AP1707A (en) 2007-02-26
CZ20021426A3 (cs) 2002-08-14
JP2003518013A (ja) 2003-06-03
KR20020073333A (ko) 2002-09-23
RU2002113654A (ru) 2004-01-27

Similar Documents

Publication Publication Date Title
US10940205B2 (en) Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
US5955454A (en) Nasal pharmaceutical composition containing a progestogen
ES2247054T3 (es) Combinacion farmaceutica de drospirenona micronizada y un estrogeno para terapia hormonal de sustitucion.
HU230162B1 (hu) Fulvesztrantot tartalmazó gyógyászati készítmény
US20100120707A1 (en) Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
US20110086825A1 (en) Therapeutic vaginal emollient
ATE216241T1 (de) Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
BR0014159A (pt) Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
CA2470703A1 (en) Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation
CO5060477A1 (es) Forma de dosificacion de nefazodona
ES2296943T3 (es) Sistema de administracion de un medicamento estrogeno tetrahidroxilado destinado a la contracepcion hormonal.
KR20030068187A (ko) 에스트로겐 대체 요법으로 치료중인 여성의 호르몬결핍증을 치료하기 위한 에스트로겐 및 안드로겐의 조합
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
KR100623788B1 (ko) 호르몬 조성물 및 이의 용도
BR0014952A (pt) Medicamento contraceptivo e seu modo de preparação
CA3177251A1 (en) Superoxide dismutase compositions and methods
PL353992A1 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
WO2017001979A1 (en) Diindolyl methane compositions, formulations and use thereof
JP3507515B2 (ja) エストリオールの高血中濃度が得られる軟膏剤
CN101987103A (zh) 一种碳酸酐酶抑制剂的眼用组合物
KR20120116871A (ko) 이관개방증 치료제
KR20010102464A (ko) 바람직하지 않은 자궁 출혈을 치료하는데 유용한 비약제조성물을 수득하기 위한 성호르몬의 용도
BR0008065A (pt) Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose
JP2001163781A (ja) 皮膚組織障害治療・予防・改善用外用剤

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]